Lease restructuring and tenant diversification - Co combined Lifepoint leases and exchanged properties to increase diversification and enhance credit profile
Key details and analyst coverage
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$259.28 mln
$250.88 mln (5 Analysts)
Q2 Net Loss
$2.29 mln
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and 3 "sell" or "strong sell"
The average consensus recommendation for the specialized REITs peer group is "buy"
Wall Street's median 12-month price target for Medical Properties Trust Inc is $5.00, about 6.4% above its August 7 closing price of $4.70
The stock recently traded at 38 times the next 12-month earnings vs. a P/E of 46 three months ago